SEC Form D · filed July 13, 2021
Kantum Pharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Glenn Batchelder · Newtown Square, PAExec · DirectorThomas Needham · Concord, NHDirectorJean-Francois Carbonneau · Concord, NHDirectorSylvie Breton · Concord, NHDirectorAndrea Franz · Waltham, MAExecCory Wallenstein · Concord, NHDirectorJean-Francois Carbonneau · Concord, NHDirectorSylvie Breton · Concord, NHDirectorGlenn Batchelder · CHELSEA, MAExec · DirectorThomas Needham · Boston, MADirectorAndrea Franz · Concord, NHExecCory Wallenstein · Concord, NHDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗